Clinical Trial Update: An Examination of Predictors of Indicators of Response to Celecoxib in Women Who Have a Diagnosis of Early Breast Cancer

View source ↗

Summary

A completed clinical study examining predictors of response indicators to the COX-2 inhibitor celecoxib in women with early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of Kansas | Conditions: Breast Cancer | Status: COMPLETED